Advertisement
Table 3 Characteristics of 13,663 patients with a first-time hospital-based diagnosis of HZ, Denmark, 1994–2012
| Characteristic | No. | Percent |
|---|---|---|
| Age group (years)a | ||
| 0–9 | 492 | (3.6) |
| 10–19 | 368 | (2.7) |
| 20–29 | 623 | (4.6) |
| 30–39 | 772 | (5.7) |
| 40–49 | 885 | (6.5) |
| 50–59 | 1650 | (12) |
| 60–69 | 2357 | (17) |
| 70–79 | 3094 | (23) |
| 80–89 | 2859 | (21) |
| ≥ 90 | 563 | (4.1) |
| Sex | ||
| Women | 7823 | (57) |
| Men | 5840 | (43) |
| Any of the comorbidities identified | 8067 | (59) |
| Charlson Comorbidity Index level | ||
| None | 6058 | (44) |
| Moderate | 2364 | (17) |
| Severe | 2374 | (17) |
| Very severe | 2867 | (21) |
| Comorbidities in the Charlson Comorbidity Index | ||
| Myocardial infarction | 921 | (6.7) |
| Congestive heart failure | 1050 | (7.7) |
| Peripheral vascular disease | 803 | (5.9) |
| Cerebrovascular disease | 1446 | (11) |
| Dementia | 256 | (1.9) |
| Chronic pulmonary disease | 1911 | (14) |
| Connective tissue disease | 983 | (7.2) |
| Ulcer disease | 848 | (6.2) |
| Mild liver disease | 171 | (1.3) |
| Diabetes without end-organ damage | 918 | (6.7) |
| Hemiplegia | 57 | (0.42) |
| Moderate to severe renal disease | 643 | (4.7) |
| Diabetes with end-organ damage | 419 | (3.1) |
| Non-metastatic solid tumor | 1755 | (13) |
| Leukemia | 489 | (3.6) |
| Lymphoma | 834 | (6.1) |
| Moderate to severe liver disease | 62 | (0.45) |
| Metastatic solid tumor | 331 | (2.4) |
| Acquired immune deficiency syndrome | 153 | (1.1) |
| Comorbidities associated with immune dysregulation | 4942 | (36) |
| Stem cell or bone marrow transplant | 273 | (2.0) |
| Solid organ transplant | 152 | (1.1) |
| Human immunodeficiency virus infection | 210 | (1.5) |
| Primary immunodeficiency | 61 | (0.45) |
| Any cancer | 2821 | (21) |
| Any autoimmune disease | 2293 | (17) |
| Hematologic | 73 | (0.53) |
| Endocrine | 614 | (4.5) |
| Central nervous system | 67 | (0.49) |
| Gastrointestinal | 274 | (2.0) |
| Skin | 315 | (2.3) |
| Connective tissue disease | 1080 | (7.9) |
| Pulmonary | 31 | (0.23) |
| Ocular | 94 | (0.69) |
